Literature DB >> 17764957

Monooxime reactivators of acetylcholinesterase with (E)-but-2-ene linker: preparation and reactivation of tabun- and paraoxon-inhibited acetylcholinesterase.

Kamil Musilek1, Ondrej Holas, Daniel Jun, Vlastimil Dohnal, Frank Gunn-Moore, Veronika Opletalova, Martin Dolezal, Kamil Kuca.   

Abstract

Acetylcholinesterase reactivators are crucial antidotes for the treatment of organophosphate intoxication. Fifteen new monooxime reactivators of acetylcholinesterase with a (E)-but-2-ene linker were developed in an effort to extend the properties of K-oxime (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203). The known reactivators (pralidoxime, HI-6, obidoxime, K075, K203) and the new compounds were tested in vitro on a model of tabun- and paraoxon-inhibited AChE. Monooxime reactivators were not able to exceed the best known compounds for tabun poisoning, but some of them did show reactivation comparable with known compounds for paraoxon poisoning. However, extensive differences were found by a SAR study for various substitutions on the non-oxime part of the reactivator molecule.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17764957     DOI: 10.1016/j.bmc.2007.08.002

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  9 in total

1.  Revealing the importance of linkers in K-series oxime reactivators for tabun-inhibited AChE using quantum chemical, docking and SMD studies.

Authors:  Shibaji Ghosh; Nellore Bhanu Chandar; Kalyanashis Jana; Bishwajit Ganguly
Journal:  J Comput Aided Mol Des       Date:  2017-06-23       Impact factor: 3.686

2.  Bisquaternary pyridinium oximes: Comparison of in vitro reactivation potency of compounds bearing aliphatic linkers and heteroaromatic linkers for paraoxon-inhibited electric eel and recombinant human acetylcholinesterase.

Authors:  Sandip B Bharate; Lilu Guo; Tony E Reeves; Douglas M Cerasoli; Charles M Thompson
Journal:  Bioorg Med Chem       Date:  2009-11-27       Impact factor: 3.641

3.  The present approaches to the development of prophylactic and therapeutic antidotes against nerve agents.

Authors:  Jiří Kassa; Jiří Bajgar; Kamil Kuča; Kamil Musílek; Jana Karasová
Journal:  Interdiscip Toxicol       Date:  2008-06

4.  The benefit of combinations of oximes for the ability of antidotal treatment to counteract sarin-induced brain damage in rats.

Authors:  Filip Caisberger; Jaroslav Pejchal; Jan Misik; Jiri Kassa; Martin Valis; Kamil Kuca
Journal:  BMC Pharmacol Toxicol       Date:  2018-06-28       Impact factor: 2.483

5.  Effect of several new and currently available oxime cholinesterase reactivators on tabun-intoxicated rats.

Authors:  Jana Zdarova Karasova; Jiri Kassa; Young-Sik Jung; Kamil Musilek; Miroslav Pohanka; Kamil Kuca
Journal:  Int J Mol Sci       Date:  2008-11-14       Impact factor: 6.208

6.  Effect of seven newly synthesized and currently available oxime cholinesterase reactivators on cyclosarin-intoxicated rats.

Authors:  Jana Zdarova Karasova; Jiri Kassa; Kamil Musilek; Miroslav Pohanka; Ladislav Novotny; Kamil Kuca
Journal:  Int J Mol Sci       Date:  2009-07-07       Impact factor: 6.208

7.  Novel Group of AChE Reactivators-Synthesis, In Vitro Reactivation and Molecular Docking Study.

Authors:  David Malinak; Eugenie Nepovimova; Daniel Jun; Kamil Musilek; Kamil Kuca
Journal:  Molecules       Date:  2018-09-07       Impact factor: 4.411

8.  Novel bisquaternary oximes--reactivation of acetylcholinesterase and butyrylcholinesterase inhibited by paraoxon.

Authors:  Kamil Kuca; Lucie Musilova; Jiri Palecek; Vladimir Cirkva; Martin Paar; Kamil Musilek; Martina Hrabinova; Miroslav Pohanka; Jana Zdarova Karasova; Daniel Jun
Journal:  Molecules       Date:  2009-12-01       Impact factor: 4.411

Review 9.  Counteracting poisoning with chemical warfare nerve agents.

Authors:  Nikolina Maček Hrvat; Zrinka Kovarik
Journal:  Arh Hig Rada Toksikol       Date:  2020-12-31       Impact factor: 2.078

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.